tiprankstipranks
Trending News
More News >
Lava Therapeutics expects $1M of expenses related to restructuring plan
PremiumThe FlyLava Therapeutics expects $1M of expenses related to restructuring plan
1M ago
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Cautious Stance on LAVA Therapeutics Amid Strategic Review and Workforce Reduction
Premium
Ratings
Cautious Stance on LAVA Therapeutics Amid Strategic Review and Workforce Reduction
2M ago
Lava Therapeutics doses first patient in Phase 1 LAVA-1266 study
PremiumThe FlyLava Therapeutics doses first patient in Phase 1 LAVA-1266 study
4M ago
LAVA Therapeutics to Transition to U.S. Domestic Issuer
Premium
Company Announcements
LAVA Therapeutics to Transition to U.S. Domestic Issuer
4M ago
Lava Therapeutics price target lowered to $2 from $6 at H.C. Wainwright
Premium
The Fly
Lava Therapeutics price target lowered to $2 from $6 at H.C. Wainwright
4M ago
LVTX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsLVTX Upcoming Earnings Report: What to Expect?
6M ago
LAVA Therapeutics Faces Financial Hurdles
Premium
Company Announcements
LAVA Therapeutics Faces Financial Hurdles
8M ago
Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year
Premium
The Fly
Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100